Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1428-1436

  Gambhir, S S ^a   Hoh, C K ^a   Phelps, M E ^a   Madar, I ^a   Maddahi, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cost effectiveness; decision analysis; non small cell lung carcinoma; PET; sensitivity analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; DIAGNOSTIC ACCURACY; HUMAN; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; DECISION TREES; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LIFE EXPECTANCY; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029743173     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Boring C, Squires T, Tong T. Cancer statistics, 1993. Ca Cancer J Clin 1993;43:7-26.
2. Patel AM, Dunn WF, Trastek VF. Staging systems of lung cancer. Mayo Clin Proc 1993;68:475-482.
3. Lince L, Lulu D. Carcinoma of the lung. A comparative series of 687 cases. Arch Surg 1971;102:103-107.
4. Hyde L, Wolf J, McCracken S, Yesner R. Natural course of inoperable lung cancer. Chest 1973;64:309-312.
5. Overholt R, Neptune W, Ashraf M. Primary cancer of the lung. A 42-year experience. Ann Thorac Surg 1975;20:511-519.
6. Benfield J, Julliard G, Pilch Y, Rigler L, Selecky P. Current and future concepts of lung cancer. Ann Intern Med 1975;83:93-106.
7. Deviri E, Schachner A, Halevy A, Shalit M, Levy M. Carcinoma of lung with a solitary cerebral metastasis. Surgical management and review of the literature. Cancer 1983;52:1507-1509.
8. Sundaresan N, Galicien J. Surgical treatment of single brain metastases from non-small-cell lung cancer. Cancer Invest 1985;3:107-113.
9. Salvatierra A, Baamonde C, Llamas J, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990;97:1052-1058.
10. Quinn D, Ostrow L, Porter D, Shelton D, Jackson D. Staging of non-small-cell bronchogenic carcinoma: relationship of the clinical evaluation to organ scans. Chest 1986;89:270-275.
11. Jacobs L, Kinkel W, Vincent R. 'Silent' brain metastasis from lung carcinoma determined by computerized tomography. Arch Neurol 1977;34:690-693.
12. Friedman P, Feigin D, Liston S, Alazraki N, Haghighi P, Young J, Peters R. Sensitivity of chest radiography, computed tomography, and gallium scanning to metastasis of lung carcinoma. Cancer 1984;54:1300-1306.
13. Bragg D. Current applications of imaging procedures in the patient with lung cancer. Int J Radiat Oncol Biol Phys 1991;21:847-851.
14. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
15. Warburg O. The metabolism of tumors. London: Constabel, 1930.
16. Weber G. Enzymology of cancer cells (Part 1). N Engl J Med 1977;296:486-493.
17. Weber G. Enzymology of cancer cells (Part 2). N Engl J Med 1977;296:541-555.
18. 18F-2-deoxyglucose. J Nucl Med 1978;19:1154-1161.
19. 18F): Nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-675.
20. Beany R. Positron emission tomography in the study of human tumors. Semin Nucl Med 1984;14:324-341.
21. Hawkins R, Phelps M. Applications of positron emission tomography (PET) in tumor management. Berlin: Springer-Verlag; 1988.
22. Pauker S, Kassirer J. The threshold approach to clinical decision making. N Engl J Med 1980;302:1109-1117.
23. Luce B, Simpson K. Methods of cost-effectiveness analysis: areas of consensus and debate. Clin Therapeutics 1995;17:109-125.
24. Weinstein M, Fineberg H, AS. E. Clinical decision analysis. Philadelphia: Saunders; 1980.
25. Habbema J, Bossuyt P, Dippel D, Marshall S, Hilden J. Analyzing clinical decision analyses. Stat Med 1990;9:1229-1242.
26. Gambhir S, Gupla P, Allen M, et al. A simulation tool for modeling cost-effectiveness with applications for determining the cost-effectiveness role of nuclear medicine studies in lung and breast cancer [Abstract]. J Nucl Med 1996;37(suppl):301P.
27. Gambhir S, Mahoney D, Turner M, et al. Symbolic interactive modeling package and learning environment (SIMPLE), a new easy method for compartmental modeling. Proc Soc Comp Sim 1996;173-186.
28. Nayor A, Elliott R, Walker W, Lamb D, Cameron E, Dark J. Role of mediastinoscopy in the diagnosis of mediastinal masses. J Royal Coll Surg Edinburgh, 1990;35:98-100.
29. Best L, Munichor M, Ben-Shakhar M, Lemer J, Liehtig C, Peleg H. The contribution of anterior mediastinotomy in the diagnosis of evaluation of diseases of the mediastinum and lung. Ann Thorac Surg 1987;43:78-81.
30. Moinuddi S, Lee L, Montgomery J. Mediastinal needle biopsy. Am J Radiol 1984;143:531-532.
31. Gross B, Glazer G, Orringer M, Spizary D, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988;166:71-74.
32. Webb W, Gatsonis C, Zerhouni E, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-713.
33. McCloud T, Bourgouin P, Greenberg R. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;183:319-323.
34. Seely J, Mayo J, Miller R, Muller N. Tl lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993;186:129-132.
35. White P, Adams H, Crane M, Butchart E. Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumors? Thorax 1994;49:951-957.
36. Primack S, Lee K, Logan P. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994;193:795-800.
37. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardio Thorac Surg 1994;8:37-42.
38. 201Tl-SPECT - comparison with CT. Radiology 1994;192:813-817.
39. Wahl R, Quint L, Greenough R, Meyer C, White R, Orringer M. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-377.
40. Madar I, Hoh C, Figlin R, et al. Cost-effective staging of non-small-cell lung carcinoma by whole-body PET-FDG imaging [Abstract]. J Nucl Med 1995;36(suppl):57p.
41. Valk P, Pounds T, Hopkins D, Haseman M, Hofer G, Greiss H. Staging lung cancer by whole-body PET-FDG imaging [Abstract]. J Nucl Med 1995;36(suppl):95p.
42. Williams D, Paircolero P, Davis C, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-76.
43. Evans E. Resection of bronchial carcinoma in the elderly. Thorax 1973;28:86-88.
44. Ginsberg R, Hill I, Eagan R, et al. Modem thirty-day operative mortality for surgical resection in lung cancer. J Thorac Cardiovasc Surg 1983;86:654-658.
45. Black WC, Armstrong P, Daniel T. Cost-effectiveness of chest CT in TlN0M0 lung cancer. Radiology 1988;167:373-378.
46. Moroff S, Pauker S. What to do when the patient outlives the literature, or DEALE-ing with a full deck. Med Decis Making 1983;3:313-338.
47. Cummings S, Illington G, Richard R. Managing solitary pulmonary nodules: the choice of strategy in a "close call." Am Rev Respir Dis 1986;134:453-460.
48. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 1985;40:558-560.
49. Best L, Munichor M, Ben-Sbakhar M, Lemer J, Lichtig C, Peleg H. The contribution of anterior mediastinotomy in the diagnosis of evaluation of diseases of the mediastinum and lung. Ann Thorac Surg 1987;43:78-81.
50. Jolly P, Hill L, Lawless P, West T. Parasternal mediastinotomy and mediastinoscopy. J Thorac Cardiovasc Surg 1983;66:549-555.
51. Cheung D, Stibal D, Weinberg S, Poleksic L. Needle aspiration biopsy as an adjunct to mediastinoscopy. South Med J 1986;79:1067-1069.
52. Weisbrod G, Lyons D, Tao L, Chamberlain D. Percutaneous fine-needle aspiration biopsy of mediastinal lesions. AJR 1984;143:525-529.
53. Moinuddi S, Lee L, Montgomery J. Mediastinal needle biopsy. AJR 1984;143:531-532.
54. Herman P, Hessel S. The diagnostic accuracy and complications of closed lung biopsies. Radiology 1977;125:11-14.
55. Schenk D, Bower J, Bryan C, et al. Transbronchial needle aspiration staging of bronchogenic carcinoma. Am Rev Respir Dis 1986;134:146-148.
56. Hartman G, Hattery R, Witten D, et al. Mortality during excretory urography: Mayo Clinic experience. AJR 1982;139:914-922.
57. McClennan B. Low-osmolality contrast media: premises and promises. Radiology 1987;162:1-8.
58. Beck J, Kassirer J, Pauker S. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med 1982;73:883-888.
59. Beck J, Pauker S and Gottlieb J. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med 1982;73:889-897.
60. Medicare Program. Federal Register 1995;60.